NCT00354016View on ClinicalTrials.gov

Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

July 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

preservative free inactivated split influenza vaccine using the strain composition 2006/2007

Trial Locations (2)

35037

Betriebsarztlicher Dienst, Universitat Marburg, Robert-Koch-Str, 5,, Marburg

35745

Werksarztzentrum Herborn, Westerwaldstr 36,, Herborn

Sponsors

Lead Sponsor

Novartis

Collaborators (1)

Novartis Vaccines
All Listed Sponsors
collaborator

Novartis Vaccines

INDUSTRY

lead

Novartis

INDUSTRY

NCT00354016 - Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects | Biotech Hunter | Biotech Hunter